Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?
Key PointsVanEck Biotech ETF offers a concentrated portfolio of 26 holdings, while State Street SPDR S&P Biotech ETF provides broad exposure to 165 companies.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
